4.7 Article

Evaluation of the Check-Points Check MDR CT103 and CT103 XL Microarray Kits by Use of Preparatory Rapid Cell Lysis

期刊

JOURNAL OF CLINICAL MICROBIOLOGY
卷 54, 期 5, 页码 1368-1371

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.03302-15

关键词

-

资金

  1. Samsung
  2. nanoMR
  3. BioFire
  4. Check-Points
  5. Curetis
  6. 3M
  7. Merck
  8. Actavis
  9. Hutchison Biofilm Medical Solutions
  10. Accelerate Diagnostics
  11. Allergan
  12. Medicines Company
  13. bioMerieux
  14. Bruker
  15. Abbott
  16. Nanosphere
  17. Siemens
  18. BD
  19. TIB

向作者/读者索取更多资源

Using a rapid bacterial lysis method, the Check MDR CT103 and CT103 XL microarrays demonstrated accuracies of 98.1% and 94.2%, respectively, for detection of known resistance genes in 108 multidrug-resistant Gram-negative bacilli. In 45 isolates, 49 previously unrecognized extended-spectrum beta-lactamase or plasmid AmpC targets were detected and confirmed by conventional PCR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据